Anders Bjartell
11 – 20 of 361
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Evaluating Biparametric Versus Multiparametric Magnetic Resonance Imaging for Diagnosing Clinically Significant Prostate Cancer : An International, Paired, Noninferiority, Confirmatory Observer Study
2024) In European Urology(
- Contribution to journal › Article
-
Mark
Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer
2024) In BJUI Compass(
- Contribution to journal › Article
-
Mark
Population-based Organised Prostate Cancer Testing : Results from the First Invitation of 50-year-old Men
(
- Contribution to journal › Article
-
Mark
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research
2024) In Nature Reviews Urology(
- Contribution to journal › Article
-
Mark
Baseline characteristics and clinical outcomes of prostate cancer patients on delayed palliative management : a PIONEER analysis based on big data
(
- Contribution to journal › Article
-
Mark
AGREE II Quality Assessment of National and International Clinical Practice Guidelines on Prostate Cancer Management by the OPTIMA Consortium
(
- Contribution to journal › Scientific review
-
Mark
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography : Results of a Multicenter European Study
(
- Contribution to journal › Article
-
Mark
Artificial intelligence for detection of prostate cancer in biopsies during active surveillance
(
- Contribution to journal › Article
-
Mark
Апалутамид в комбинации с андрогендепривационной терапией в клинических подгруппах пациентов с метастатическим кастрационно-чувствительным раком предстательной железы : подгрупповой анализ рандомизированного клинического исследования TITAN
(
- Contribution to journal › Article
-
Mark
Investigating Ras homolog gene family member C (RhoC) and Ki67 expression following external beam radiation therapy show increased RhoC expression in relapsing prostate cancer xenografts
(
- Contribution to journal › Article